FlowPed

Company Overview

Snapshot

Founded in January 2024 by David Grey, Lee Sahar, and Noam Hadas, FlowPed operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its innovative health treatment platform.

Business overview

FlowPed is developing a novel nursing and diagnostic platform to improve care for individuals with moderate to severe bladder control difficulties. The company's core technology includes Dry-One, a self-drying interactive pad, and a remote patient data monitoring platform. This platform provides continuous transparency of a patient's condition, enabling targeted treatment and symptom reduction, alongside AI-enabled analysis for identifying dehydration and urinary infections. FlowPed serves the digital healthcare market, specifically targeting the aging population and patients in need of remote monitoring solutions.

Company Intelligence Q&A

What is FlowPed's primary focus?

FlowPed focuses on developing a novel nursing and diagnostic platform for individuals suffering from moderate to severe bladder control difficulties, aiming to improve current care methods.

What is the Dry-One product?

Dry-One is a self-drying interactive pad developed by FlowPed, designed to be changed only once every 24 hours, offering an improved solution for incontinence management.

How does FlowPed utilize AI?

FlowPed's remote patient data monitoring platform incorporates AI-enabled analysis to identify developing dehydration and the onset of urinary infections, providing proactive health insights.

When was FlowPed founded?

FlowPed was founded in January 2024.

Who are the founders of FlowPed?

FlowPed was founded by David Grey, Lee Sahar, and Noam Hadas.